EXTRAMMUNE

Main information

  • Trade name:
  • EXTRAMMUNE 200ML SYR
  • Pharmaceutical form:
  • SYR
  • Composition:
  • 200ML
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EXTRAMMUNE 200ML SYR
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

28-11-2017

Scientific guideline:  Guideline on the assessment of clinical safety and efficacy in the preparation of EU herbal monographs for well-established and traditional herbal medicinal products - Revision 1, adopted

Scientific guideline: Guideline on the assessment of clinical safety and efficacy in the preparation of EU herbal monographs for well-established and traditional herbal medicinal products - Revision 1, adopted

This guideline describes the legal background and recommendations for the assessment of data that are used to prepare European Union herbal monographs (formerly called Community herbal monographs) on herbal medicinal products and the European Union list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products. The areas of herbal medicinal products with well-established medicinal use and traditional herbal medicinal products are addressed.

Europe - EFSA - European Food Safety Authority EFSA Journal

24-11-2017

Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall of Riomet® (Metformin Hydrochloride Oral Solution) Manufactured by a Contract Manufacturer due to Microbial Contamination

Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall of Riomet® (Metformin Hydrochloride Oral Solution) Manufactured by a Contract Manufacturer due to Microbial Contamination

Sun Pharmaceutical Industries, Inc. (SPII), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” including its subsidiaries and/or associate companies) is voluntarily recalling two lots of Riomet® (Metformin Hydrochloride Oral Solution), 500 mg/5mL, to the retail level (Class II Recall). This product is manufactured for SPII by a contract manufacturer. The Riomet® (Metformin Hydrochloride Oral Solution) has been fo...

FDA - U.S. Food and Drug Administration

23-10-2017

Octagam [Immune Globulin Intravenous (human)] 10 Percent Liquid Preparation]: Voluntary Market Withdrawal

Octagam [Immune Globulin Intravenous (human)] 10 Percent Liquid Preparation]: Voluntary Market Withdrawal

Suspend further administration of octagam 10% from production lots K724B8541 and K725A8541.

FDA - U.S. Food and Drug Administration

4-8-2017

Balguti Kesaria Ayurvedic Medicine: FDA Warning - High Levels Of Lead

Balguti Kesaria Ayurvedic Medicine: FDA Warning - High Levels Of Lead

Exposure to lead can cause serious damage to the central nervous system, the kidneys and the immune system.

FDA - U.S. Food and Drug Administration

19-1-2018

Colonoscopy (Test, Side Effects, Preparation, Recovery)

Colonoscopy (Test, Side Effects, Preparation, Recovery)

Title: Colonoscopy (Test, Side Effects, Preparation, Recovery)Category: Procedures and TestsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 1/19/2018 12:00:00 AM

US - MedicineNet

21-11-2017

Workshops: Codeine up-scheduling

Workshops: Codeine up-scheduling

These sessions are designed to ensure health professionals dealing with chronic and acute pain management have alternative strategies to use in preparation for 1 February and beyond.

Therapeutic Goods Administration - Australia